COMPAREMEDSRX Trademark

Trademark Overview

On Thursday, April 28, 2022, a trademark application was filed for COMPAREMEDSRX with the United States Patent and Trademark Office. The USPTO has given the COMPAREMEDSRX trademark a serial number of 97386709. The federal status of this trademark filing is REGISTERED as of Tuesday, May 28, 2024. This trademark is owned by Garsantis, Inc.. The COMPAREMEDSRX trademark is filed in the Advertising, Business and Retail Services category with the following description:

Providing online price comparisons of prescription and over-the counter medications between various pharmaceutical discount platforms for consumers and other participants in the field of healthcare via the Internet
comparemedsrx

General Information

Serial Number97386709
Word MarkCOMPAREMEDSRX
Filing DateThursday, April 28, 2022
Status700 - REGISTERED
Status DateTuesday, May 28, 2024
Registration Number7403738
Registration DateTuesday, May 28, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkCOMPARE MEDS RX
Goods and ServicesProviding online price comparisons of prescription and over-the counter medications between various pharmaceutical discount platforms for consumers and other participants in the field of healthcare via the Internet

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateTuesday, May 3, 2022
Primary Code035
First Use Anywhere DateTuesday, October 31, 2023
First Use In Commerce DateTuesday, October 31, 2023

Trademark Owner History

Party NameGarsantis, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSchaumburg, IL 60173
Party NameGarsantis, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSchaumburg, IL 60173

Trademark Events

Event DateEvent Description
Monday, May 2, 2022NEW APPLICATION ENTERED
Tuesday, May 3, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, February 15, 2023ASSIGNED TO EXAMINER
Wednesday, February 22, 2023NON-FINAL ACTION WRITTEN
Wednesday, February 22, 2023NON-FINAL ACTION E-MAILED
Wednesday, February 22, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 15, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Monday, August 21, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 15, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Monday, August 21, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 21, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 25, 2023FINAL REFUSAL WRITTEN
Monday, September 25, 2023FINAL REFUSAL E-MAILED
Monday, September 25, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, December 15, 2023TEAS AMENDMENT OF USE RECEIVED
Friday, December 15, 2023TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, December 15, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, December 16, 2023USE AMENDMENT FILED
Saturday, December 16, 2023AMENDMENT TO USE PROCESSING COMPLETE
Saturday, December 16, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 28, 2023USE AMENDMENT ACCEPTED
Thursday, December 28, 2023NON-FINAL ACTION WRITTEN
Thursday, December 28, 2023NON-FINAL ACTION E-MAILED
Thursday, December 28, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, December 29, 2023NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Monday, March 18, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 22, 2024APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Tuesday, May 28, 2024REGISTERED-SUPPLEMENTAL REGISTER
Tuesday, May 28, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Monday, March 18, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 18, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED

Related Keywords

comparemedsrx consumers platforms discount other participants internet healthcare field pharmaceutical various